N O . 5 1 | N O V E M B E R 2 0 1 8 C A N N A B I S N E W S A R O U N D T H E W O R L D verdecann Above: FCM Global's Proprietary VerdeCann Strain World Health U.S. Congress Is The Most Impactful Organization to Review Going to Make Cannabis Studies Cannabis Scheduling Marijuana Moves of All Time PG. 4 PG. 6 PG. 8 verdecann CONTENTS 04 WHO to Review Cannabis Scheduling Cannabis reform is now on the march at the highest level of international discussion 06 Congress Is Going to Make Marijuana Moves It’s a common-sense policy change that is long overdue 08 The Most Impactful Cannabis Studies of All Time Landmark cannabis studies exclusively focused on fundamentally advanced our understanding of the plant’s therapeutic properties, or thoroughly debunked 15 Medical Cannabis for Pets Many pet owners are hearing about the potential benefits and wonder if it can be applicable for their furry friends 17 Brewers Are Putting Cannabis Into Cans Marijuana derivatives — from THC to terpenes — are showing up in beers and nonalcoholic drinks 21 How Cannabis Affects Men & Women Differently Could marijuana affect men and women in different ways? 23 Cannabis and the Brain Recent studies shed new light FCM Global's Quality Control Lab 25 Designing for the New Culture of Cannabis Top-tier designers are making the face of marijuana more beautiful, smart, and inviting Sunita Arnold Editor & Publisher Chief Marketing Officer FCM Global S.A.S. 28 [email protected] These Sparkling CBD Drinks Have Replaced My La Inquires, Questions & Comments Croix Habit For Good Please email [email protected] A one-two punch of millennial chilled-out bliss V E R D E C A N N | W W W . F C M - G L O B A L . C O M | 2 N O V E M B E R 2 0 1 8 Quick Hits cannabis news around the world news business culture Thousands of Patients in Limbo Why Does GDPR Matter for McLegalization: as Israeli Ministry Temporarily The Cannabis Industry? Cannabis Culture on Campus Shuts Top Cannabis Grower The Health Ministry has issued a As the industry goes global, there is a Whether or not the substance will be temporary stop work order against new game in town on the regulatory completely accepted into campus Israel’s largest medical cannabis side - the EU’s data protection culture is a question that remains company, Tikun Olam. regulations. unanswered. R E A D M O R E R E A D M O R E R E A D M O R E 10 Cannabis Executives Predict Lack of Legal Cannabis Seeds The Women Of Wine Country How AG Jeff Sessions' Fuels Spike in Black-Market Staking A Claim In Cannabis Retirement Will Affect the Sales Marijuana Industry The future of the marijuana industry Some illegal cannabis seed vendors Wine, beer and other marijuana- could change with anti-cannabis Jeff are reporting big spikes in sales, infused adult beverages are the next Sessions out as Attorney General. driven by the lack of legal seed supply frontier in the legal cannabis industry outside the medical marijuana system. as the over-21 market expands. R E A D M O R E R E A D M O R E R E A D M O R E Britain Welcomes the Global Cannabis Industry Is Facing a Cannabis Being Used in Cannabis Revolution Shakeout, Aphria President Makeup Products is on the Rise Says The British government has Many in the industry believe it’s Sephora announced the launch of its added cannabis to the medicines headed for a wave of consolidation as ‘High Beauty’ range earlier this year. available to patients on the companies adjust to the realities of National Health Service. the market. R E A D M O R E R E A D M O R E R E A D M O R E Thailand Marijuana Bill Challenges Breed Innovation: Entrepreneur Wants to Turn Shortened to Allow Quicker Marketing Cannabis Brands in Canada’s Cannabis Waste into Legislation Canada Prosthetic Limbs With only 17 articles, cannabis The restrictions that have been placed A Halifax entrepreneur says he can may become legal next month. on cannabis branding are less than source the raw materials for his line of ideal for marketers. plastic prosthetic limbs from the country’s dire new problem with legal cannabis over-packaging. R E A D M O R E R E A D M O R E R E A D M O R E V E R D E C A N N | W W W . F C M - G L O B A L . C O M | 3 INDUSTRY | NOVEMBER 2018 WORLD HEALTH ORGANIZATION NOVEMBER MEETING TO REVIEW CANNABIS The organization is currently preparing for a review of cannabis scheduling and classification at its November meeting with a recommendation from this summer that CBD had no addictive properties. REPOST: MARGUERITE ARNOLD / CANNABIS INDUSTRY JOURNAL / OCTOBER 30, 2018 CONTINUED ON PG. 5 V E R D E C A N N | W W W . F C M - G L O B A L . C O M | 4 INDUSTRY | NOVEMBER 2018 In a sign that cannabis reform is now on the march Here is why: The WHO is effectively examining both at the highest level of international discussion, the the addictive impact and “harm” of the entire plant, World Health Organization (WHO) will be meeting in by cannabinoid, while admitting, already that current November to formally review its policies on scheduling is inappropriate. And further should not cannabis. This will be the second time in a year that apply to CBD. the organization has met to review its policies on the plant, with a direct knock-on effect at the UN This also means that come November, the level. committee, which has vast sway on the actions of the UN when it comes to drug policy, is already in According to documents obtained by Cannabis the CBD camp. And will finally, it is suspected, place Industry Journal, including a personal cover other cannabinoids within a global rescheduling letter over the committee’s findings submitted to scheme. AKA removing any justification for the Secretary-General Antonio Guterres by Dr. sovereign laws, as in the U.S., claiming that any part Tedros Adhanom Ghebreyesus, Director-General of of cannabis is a “Schedule I” drug. the WHO, the November review will “undertake a critical review of the…cannabis plant and resin; What this means, in other words, in effect, is that as extracts and tinctures of cannabis.” of November, the UN will have evidence that its current drug scheduling of cannabis, at the What Exactly Will The WHO Review? international level, is not only outdated, but needs a 21stcentury reboot. The November meeting will follow up on the work done this summer in June – namely to review CBD. International Implications According to these recommendations, the fortieth meeting of the Expert Committee on Drug Dependence (ECDD) in Geneva will include the This also means that as of November, globally, the following: current American federal justifications and laws for keeping cannabis a Schedule I drug, and based on the same, will have no international legal or Pure CBD should not be scheduled within scientific legitimacy or grounding. International Drug Control Conventions. Cannabis plant and resin, extracts and Not that this has stopped destructive U.S. policies tinctures of cannabis, Delta-9-THC and before. See global climate change. However, and this isomers of THC will all be reviewed in is the good news, it is far easier to lobby on November. cannabis reform locally than CO2 emissions far from home. See the other potentially earth-shaking event Finally, and most cheeringly, the committee in November – namely the U.S. midterm elections. concluded that “there is sufficient information to progress Delta-9-THC to a critical review…to The global industry, in other words, is about to get a address the appropriateness of its placement shot in the arm, and in a way that has never within the Conventions.” In other words, happened before in the history of the plant. rescheduling. And that is only good news for not only the industry, Industry and Patient Impact but consumers and patients alike. Translation beyond the diplomatic niceties? The drug war may, finally, and at a level not seen for more than a century, come to a close internationally, on cannabis. V E R D E C A N N | W W W . F C M - G L O B A L . C O M | 5 INDUSTRY | NOVEMBER 2018 CONGRESS IS GOING TO MAKE MARIJUANA MOVES REPOST: Paul Armentano / Opinion - The Hill / November 14, 2018 Despite majority public support in favor of marijuana legalization, and super-majority support in favor of medical cannabis access, members of Congress have nonetheless been reticent to move forward with any significant changes to federal pot policy. That is, until now. Following last week’s midterm election results, The language also for the first time amends the legislative leaders in both the House and Senate federal Controlled Substances Act of 1970 so that appear ready to take on the cannabis issue. On industrial hemp plants containing no more than Friday, Senate Majority Leader Mitch McConnell (R- 0.3 percent THC are no longer classified as a Ky.) pledged that language lifting the federal schedule I controlled substance. This change government’s longstanding ban on industrial would green light states to regulate the crop’s hemp will be included in the engrossed version of production and retail sale free from federal interference.